TrialBlood2022
Recombinant von Willebrand factor prophylaxis in patients with severe von Willebrand disease: phase 3 study results.
Frank W G Leebeek et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
28 papers cite it
this papertrialcites it